Track topics on Twitter Track topics that are important to you
Suite 11058 South Service Road
United States of America
Phone: (631) 962-2000
Fax: (631) 752-3880
Roche lung cancer drug wins further EU approval
A look at today's forthcoming news stories: Tarceva approved as non small cell lung cancer maintenance treatment, there are calls to halt Avandia clinical trial in the US, and turmeric could the spice...
The combination of bevacizumab (Avastin) and erlotinib (Tarceva) is superior to erlotinib alone as upfront treatment for non–small cell lung cancer harboring EGFR mutations.
Top stories on December 17th, 2009: Mapping cancer: The genetic mutations that turn healthy cells into tumours OSI "could lose US $400M sales" after Tarceva's turned down Celgene's psoriasis s...
Portola touts exec's commercial management experience with Genentech success stories Avastin and Tarceva.
It turns out handfuls of allosteric mutant oncogenes are targetable with a single inhibitor. Read how newco Black Diamond Therapeutics – co-founded by leaders behind first-gen TKI Tarceva alongside ...
These highlights do not include all the information needed to use TARCEVA safely and effectively. See full prescribing information for TARCEVA. TARCEVA (erlotinib hydrochloride) tablet for oral use In...
A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-Small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens
This is a multicenter, open-label, randomized phase 1 study of escalating doses of Tarceva in patients with advanced NSCLC who currently smoke. Part I will establish the maximum tolerated...
The purpose of this study is test the safety of Tarceva, find the best dose, and see what effects (good and bad) it has on you and your colorectal cancer. The effects of Tarceva will be e...
This is a phase II study of Bevacizumab plus Temodar and Tarceva in patients with non-progressive glioblastoma or gliosarcoma. Patients must have stable disease immediately following a sta...
This study is designed to identify biomarkers which may predict improvement in progression free survival from treatment with Tarceva, in patients with advanced pancreatic cancer who failed...
This study will compare the efficacy and safety of escalating versus standard doses to rash of Tarceva, in combination with gemcitabine, in patients with metastatic pancreatic cancer. Duri...
OSI Pharmaceuticals is committed to “shaping medicine and changing lives” by developing and commercializing high-quality and novel pharmaceutical products that extend life or improve the quality o...
Hana Biosciences, Inc. (Nasdaq: HNAB) is a biopharmaceutical company dedicated to developing new, differentiated cancer therapies designed to improve and enable current standards of care. The Com...
We have published hundreds of TARCEVA news stories on BioPortfolio along with dozens of TARCEVA Clinical Trials and PubMed Articles about TARCEVA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TARCEVA Companies in our database. You can also find out about relevant TARCEVA Drugs and Medications on this site too.